Neuropeptides and the regulation of islet function

Diabetes

Volumn 55, Issue SUPPL. 2, 2006, Pages

  Ahrén, Bo ^a   Wierup, Nils ^a   Sundler, Frank ^a  

^a B11 BMC ^*

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CALCITONIN GENE RELATED PEPTIDE; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; GALANIN; GASTRIN RELEASING PEPTIDE; GLUCAGON; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INSULIN; NEUROPEPTIDE; NEUROPEPTIDE Y; NORADRENALIN;

AUTONOMIC NERVE; DIABETES MELLITUS; GLUCAGON RELEASE; HYPOGLYCEMIA; INNERVATION; INSULIN RELEASE; NERVE CONDUCTION; NEUROTRANSMISSION; NONHUMAN; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; REVIEW; SENSORY NERVE; SYMPATHETIC NERVE;

EID: 33845543747     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-S013     Document Type: Review

References (62)

1. Woods SC, Porte D Jr: Neural control of the endocrine pancreas. Physiol Rev 54:596-619, 1974
2. Sundler F, Böttcher G: Islet innervation, with special reference to neuropeptides. In The Endocrine Pancreas. Samols E, Ed. New York, Raven Press, 1991, p. 29-52
3. Ahrén B: Autonomic regulation of islet hormone secretion: implications for health and disease. Diabetologia 43:393-410, 2000
4. Ahrén B: Neuropeptides and insulin secretion. In International Textbook of Diabetes Mellitus. 3rd ed. DeFronzo RA, Ferrannini E, Keen H, Zimmet P, Eds. Chichester, U.K., Wiley, 2004, p. 153-163
5. Kohnert KD, Myrsén-Axcrona U, Hehmke B, Klöting I, Sundler F, Ahrén B: Islet neuronal abnormalities associated with impaired insulin secretion in type 2 diabetes in the Chinese hamster. Regul Pept 82:71-79, 1999
6. Ahrén B: Type 2 diabetes, insulin secretion and β-cell mass. Curr Mol Med 5:275-286, 2005
7. Ahrén B, Holst JJ: The cephalic insulin response to meal ingestion in humans is dependent both on cholinergic and noncholinergic mechanisms and is important for postprandial glycemia. Diabetes 50:1030-1038, 2001
8. Taborsky GJ Jr, Ahrén B, Havel PJ: Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired β-cell responses in type-1 diabetes. Diabetes 47:995-1005, 1998
9. Havel PJ, Ahrén B: Activation of autonomic nerves and the adrenal medulla contributes to increased glucagon secretion during moderate insulin-induced hypoglycemia in women. Diabetes 46:801-807, 1997
10. Schwartz TW, Holst JJ, Fahrenkrug J, Jensen SL, Nielsen OV, Rehfeld JF, de Muckadell OB, Stadil F: Vagal, cholinergic regulation of pancreatic polypeptide secretion. J Clin Invest 61:781-789, 1978
11. Ahrén B, Paquette TL, Taborsky GJ Jr: Effect and mechanism of vagal nerve stimulation of somatostatin secretion in dogs. Am J Physiol 250:E212-E217, 1986
12. Schwartz TW: Pancreatic polypeptide: a unique model for vagal control of endocrine systems. J Auton Nerv Syst 9:99-111, 1983
13. Sheikh SP, Holst JJ, Skak Nielsen T, Knigge U, Warberg J, Theodorsson-Norheim E, Hökfelt T, Lindberg JM, Schwartz TW: Release of NPY in pig pancreas: dual parasympathetic and sympathetic regulation. Am J Physiol 255:G46-G54, 1988
14. Wierup N, Richards WG, Bannon AW, Kuhar MJ, Ahrén B, Sundler F: CART knock out mice have impaired insulin secretion and glucose intolerance, altered beta cell morphology and increased body weight. Regul Pept 129:203-211, 2005
15. Wierup N, Kuhar MJ, Nilsson BO, Mulder H, Ekblad E, Sundler F: Cocaine-and amphetamine-regulated transcript (CART) is expressed in several islet cell types during rat development. J Histochem Cytochem 52:169-177, 2004
16. Filipsson K, Sundler F, Hannibal J, Ahrén B: PACAP and PACAP receptors in insulin producing tissues: localization and effects. Regul Pept 74:167-175, 1998
17. Knuthsen S, Holst JJ, Baldissera FG, Skak-Nielsen T, Poulsen SS, Jensen SL, Nielsen OV: Gastrin-releasing peptide in the porcine pancreas. Gastroenterology 92:1153-1158, 1987
18. Ahrén B: PACAP and the endocrine pancreas. In Pituitary Adenylate Cyclase-Activating Polypeptide. Vaudry H, Arimura A, Norewll MA, Eds. Dordrecht, the Netherlands, Kluwer Academic, 2003, p. 185-206
19. Wood SM, Jung RT, Webster JD, Ghatei MA, Adrian TE, Yanaihara N, Yanaihara C, Bloom SR: The effect of the mammalian neuropeptide, gastrin-releasing peptide (GRP), on gastrointestinal and pancreatic hormone secretion in man. Clin Sci 65:365-371, 1983
20. Kato I, Suzuki Y, Kabane A, Yonekura H, Tanaka O, Kondo H, Takasawa S, Yoshimoto T, Okamoto H: Transgenic mice overexpressing human vasoactive intestinal peptide (VIP) gene in pancreatic beta cells: evidence for improved glucose tolerance and enhanced insulin secretion by VIP and PHM-27. J Biol Chem 269:1223-1228, 1994
21. Yamamoto K, Hashimoto H, Tomimoto S, Shintani N, Miyazaki H, Tashiro F, Aihara H, Nammo T, Li M, Yamagata K, Miyagawa J, Matsuzawa Y, Kawabata Y, Fukuyama Y, Koga K, Mori W, Tanaka K, Matsuda T, Baba A: Overexpression of PACAP in transgenic mouse pancreatic β-cells enhances insulin secretion and ameliorates streptozotocin-induced diabetes. Diabetes 52:1155-1162, 2003
22. Shintani N, Tomimoto S, Hashimoto H, Kawaguchi C, Baba A: Functional roles of the neuropeptide PACAP in brain and pancreas. Life Sci 74:337-343, 2003
23. Aton SJ, Colwell CS, Harmar AJ, Waschek H, Herzog ED: Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons. Nat Neurosci 8:476-483, 2005
24. Jamen F, Persson K, Bertrand G, Rodriguez-Henche N, Puech R, Bockaert J, Ahrén B, Brabet P: PAC1 receptor-deficient mice display impaired insulinotropic response to glucose and reduced glucose tolerance. J Clin Invest 105:1307-1315, 2000
25. Karlsson S, Bood M, Ahrén B: The mechanism of 2-deoxy-D-glucose- induced insulin secretion in the mouse. J Autonom Pharmacol 7:135-144, 1987
26. Filipsson K, Holst JJ, Ahrén B: PACAP contributes to insulin secretion after gastric glucose gavage in mice. Am J Physiol 279:R424-R432, 2000
27. Tornøe K, Hannibal J, Fahrenkrug J, Holst JJ: PACAP-(1-39) as neurotransmitter in pig pancreas: receptor activation revealed by the antagonist PACAP-(6-38). Am J Physiol 273:G436-G446, 1997
28. Ahrén B: The insulin response to gastric glucose is reduced in PAC1 and GRP receptor gene deleted mice. Nutr Metab Cardiovasc Dis 16:S17-S21, 2006
29. Asnicar MA, Köster A, Heiman ML, Tinsley F, Smith DP, Galbreath E, Fox N, Linda Y, Blum WF, Hsiung HM: Vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating peptide receptor 2 deficiency in mice results in growth retardation and increased basal metabolic rate. Endocrinology 143:3994-3006, 2002
30. Persson K, Ahrén B: The neuropeptide PACAP contributes to the glucagon response to insulin-induced hypoglycemia in mice. Acta Physiol Scand 175:24-28, 2002
31. Yada T, Sakurada M, Filipsson K, Kikuchi M, Ahrén B: Intraperitoneal PACAP administration decreases blood glucose in GK rats, and in normal and high-fat diet mice. Ann N Y Acad Sci 921:259-263, 2000
32. Tsutsumi M, Claus TH, Liang Y, Li Y, Yang L, Zhu J, Dela Cruz F, Peng X, Cheng H, Yung SL, Hamren DS, Livingston JN, Pan CQ: A potent and highly selective VPAC2 agonist enhances glucose-induced insulin release and glucose disposal. Diabetes 51:1453-1460, 2002
33. Persson K, Pacini G, Sundler F, Ahrén B: Islet function phenotype in gastrin-releasing peptide gene deficient mice. Endocrinology 143:3717-3726, 2002
34. Persson K, Gingerich RL, Nayak S, Wada K, Wada E, Ahrén B: Reduced GLP-1 and insulin responses and glucose intolerance after gastric glucose in GRP receptor deleted mice. Am J Physiol 279:E956-E962, 2000
35. Hunter RG, Kuhar MJ: CART peptides as targets for CNS drug development. Curr Drug Target CNS Neurol Disord 3:201-205, 2003
36. Wierup N, Sundler F: CART is a novel islet regulatory peptide. Peptides 27:2031-2036, 2006
37. Wierup N, Björkquist M, Kuhar MJ, Mulder H, Sundler F: CART regulates islet hormone secretion and is expressed in the β-cells of type 2 diabetic rats. Diabetes 55:305-311, 2006
38. Kvist Reimer M, Sundler F, Ahrén B: Effects of chemical sympathectomy by means of 6-hydroxydopamine on insulin secretion and islet morphology in alloxan-diabetic mice. Cell Tissue Res 307:203-209, 2002
39. Karlsson S, Myrsén U, Nieuwenhuizen A, Sundler F, Ahrén B: Presynaptic sympathetic mechanism in the insulinostatic effect of epinephrine in mouse pancreatic islets. Am J Physiol 272:R1371-R1378, 1997
40. Ahrén B, Lundquist I: Adrenalectomy and chemical sympathectomy by 6-hydroxydopamine: effects on basal and stimulated insulin secretion. Pflü gers Arch 390:17-21, 1981
41. Dunning BE, Ahrén B, Veith RC, Taborsky GJ Jr: Non-adrenergic sympathetic neural influences on basal pancreatic hormone secretion. Am J Physiol 255:E785-E790, 1988
42. Ahrén B, Lindskog S: Galanin and the regulation of islet hormone secretion. Int J Pancreatol 11:147-160, 1992
43. Dunning BE, Taborsky GJ Jr: Galanin release during pancreatic nerve stimulation is sufficient to influence islet function. Am J Physiol 256:E191-E198, 1989
44. Dunning BE, Karlsson S, Ahrén B: Contribution of galanin to stress-induced impairment of insulin secretion in swimming mice. Acta Physiol Scand 143:145-152, 1991
45. Ahrén B, Pacini G, Wynick D, Wierup N, Sundler F: Loss-of-function mutation of the galanin gene is associated with perturbed islet function in mice. Endocrinology 145:3190-3196, 2004
46. Karlsson S, Sundler F, Ahrén B: Neonatal capsaicin-treatment in mice: effects on pancreatic peptidergic nerves and 2-deoxy-D-glucose-induced insulin and glucagon secretion. J Autonom Nerv Syst 39:51-60, 1992
47. Karlsson S, Scheurink AJW, Steffens AB, Ahrén B: Involvement of capsaicin-sensitive nerves in regulation of insulin secretion and glucose tolerance in conscious mice. Am J Physiol 267:R1071-R1077, 1993
48. Ahrén B, Pettersson M: Calcitonin gene-related peptide (CGRP) and amylin and the endocrine pancreas. Int J Pancreatol 6:1-15, 1990
49. Gram DX, Hansen AJ, Wilken M, Elm T, Svendsen O, Carr RD, Ahrén B, Brand CL: Plasma calcitonin gene-related peptide is increased prior to obesity, and sensory nerve desensitization by capsaicin improves oral glucose tolerance in obese Zucker rats. Eur J Endocrinol 153:963-969, 2005
50. Moesgaard SG, Brand CL, Sturis J, Ahrén B, Wilken M, Fleckner J, Carr RD, Svendsen O, Hansen AJ, Gram DX: Sensory nerve inactivation by resiniferatoxin improves insulin sensitivity in male obese Zucker rats. Am J Physiol 288:E1137-E1145, 2005
51. Gram DX, Hansen AJ, Deacon CF, Brand CL, Ribel U, Wilken M, Carr RD, Svendsen O, Ahrén B: Sensory nerve desensitization by resiniferatoxin improves glucose tolerance and increases insulin secretion in Zucker diabetic fatty rats and is associated with reduced plasma activity of dipeptidyl peptidase IV. Eur J Pharmacol 509:211-217, 2005
52. Ahrén B, Gudbjartsson T, Naser Al-Amin A, Mårtensson H, Myrsén-Axcrona U, Karlsson S, Mulder H, Sundler F: Islet perturbations in insulin resistant high-fat fed rats. Pancreas 18:75-83, 1999
53. Ahrén B, Simonsson E, Scheurink AJW, Mulder H, Myrsén U, Sundler F: Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice. Metabolism 46:97-106, 1997
54. Ahrén B, Lundquist I: Modulation of basal insulin secretion in the obese, hyperglycemic mouse. Metabolism 31:172-179, 1982
55. Ahrén B, Sauerberg P, Thomsen C: Increased insulin secretion and normalization of glucose tolerance by cholinergic agonism in high-fat fed C57BL/6J mice. Am J Physiol 277:E93-E102, 1999
56. Portha B: Programmed disorders of β-cell development and function as one cause of type 2 diabetes? The GK rat paradigm. Diabetes Metab Res Rev 21:495-504, 2005
57. Ktorza A, Bernard C, Parent V, Penicaud L, Froguel P, Lathrop M, Gaugier D: Are animal models of diabetes relevant to study of the genetics of non-insulin-dependent diabetes in humans? Diabetes Metab 23 (Suppl. 2):38-46, 1997
58. Myrsén U, Ahrén B, Sundler F: Dexamethasone-induced NPY expression in rat islet endocrine cells: rapid reversibility and partial prevention by insulin. Diabetes 45:1306-1316, 1996
59. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC: β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110, 2003
60. Perfetti R, Hui H: The role of GLP-1 in the life and death of pancreatic beta cells. Horm Metab Res 36:804-810, 2004
61. Edvell A, Lindström P: Vagotomy in young obese hyperglycemic mice: effects on syndrome development and islet proliferation. Am J Physiol 274:E1034-E1039, 1998
62. Tsunekawa S, Miura Y, Yamamoto N, Itoh N, Ariyoshi Y, Senda T, Oiso Y, Niki I: Systemic administration of pituitary adenylate cyclase-activating polypeptide maintains beta-cell mass and retards onset of hyperglycaemia in beta-cell-specific calmodulin-overexpressing transgenic mice. Eur J Endocrinol 152:805-811, 2005